Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Isogai

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 24, 2001
[Susceptibility testing of clinical strains of Legionella spp. isolated in Japan]H Murakami, T Matsumoto, T Kobayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1997
[Clinical investigation of prostatic cancer patients who underwent radical prostatectomy: analysis of patients in the Tokai Urological Cancer Registry]N Hayashi, J Kawamura, K Fujita, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1983
[The study of infiltrating lymphocytes in the tissues of bladder carcinoma]Y Fujimoto, Y Hasegawa, N Kato, et al.
Clinical Genetics|April 1, 1997
Marinesco-Sjögren syndrome associated with acute myeloblastic leukemiaS Fukuda, Y Yamada, M Nishimura, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Correlation between the pharmacological efficacy of cyclosporine and tacrolimus as evaluated by the lymphocyte immunosuppressant sensitivity test (LIST) and the MTT assay procedure in patients before and after renal transplantationK Sugiyama, K Isogai, A Toyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Journal of Inherited Metabolic Disease|March 21, 1998
Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease)K Isogai, K Sukegawa, S Tomatsu, et al.
Human Mutation|January 1, 1995
Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patientsK Sukegawa, S Tomatsu, T Fukao, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2012
Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experimentNina Lathia, Pierre K Isogai, Scott E Walker, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantationK Sugiyama, K Isogai, A Toyama, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 24, 2001
[Susceptibility testing of clinical strains of Legionella spp. isolated in Japan]H Murakami, T Matsumoto, T Kobayashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1997
[Clinical investigation of prostatic cancer patients who underwent radical prostatectomy: analysis of patients in the Tokai Urological Cancer Registry]N Hayashi, J Kawamura, K Fujita, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1983
[The study of infiltrating lymphocytes in the tissues of bladder carcinoma]Y Fujimoto, Y Hasegawa, N Kato, et al.
Clinical Genetics|April 1, 1997
Marinesco-Sjögren syndrome associated with acute myeloblastic leukemiaS Fukuda, Y Yamada, M Nishimura, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Correlation between the pharmacological efficacy of cyclosporine and tacrolimus as evaluated by the lymphocyte immunosuppressant sensitivity test (LIST) and the MTT assay procedure in patients before and after renal transplantationK Sugiyama, K Isogai, A Toyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Journal of Inherited Metabolic Disease|March 21, 1998
Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease)K Isogai, K Sukegawa, S Tomatsu, et al.
Human Mutation|January 1, 1995
Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patientsK Sukegawa, S Tomatsu, T Fukao, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2012
Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experimentNina Lathia, Pierre K Isogai, Scott E Walker, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantationK Sugiyama, K Isogai, A Toyama, et al.
Pageof 9